This study indicates that HBeAg status, age, ethnic origin with longitudinal assessment of LFTs, and viral load should be studied in patients with “normal ALT” at the upper end of normal range (ALT 20–40 IU/L) to appropriately classify patients and identify patients for liver fibrosis assessment to inform treatment decisions. This evidence concerns the gene GPT and Hepatic fibrosis.